Defining a minimal clinically meaningful difference in 12-month estimated glomerular filtration rate for clinical trials in deceased donor kidney transplantation.

Mayne, Tracy J; Nordyke, Robert J; Schold, Jesse D; Weir, Matthew R; Mohan, Sumit

Mayne, Tracy J; Nordyke, Robert J; Schold, Jesse D; Weir, Matthew R; Mohan, Sumit.

Affiliation

Mayne TJ; Angion Biomedica, San Francisco, California, USA.
Nordyke RJ; Angion Biomedica, San Francisco, California, USA.
Schold JD; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
Weir MR; Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Mohan S; Department of Medicine, Division of Nephrology, Vagelos College of Physicians & Surgeons and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.

Clin Transplant ; 35(7): e14326, 2021 07.

Article in En | MEDLINE | ID: mdl-33896052

Subject(s)

Kidney Transplantation; Glomerular Filtration Rate; Graft Survival; Humans; Kidney; Time Factors

Key words

clinical trial design; glomerular filtration rate; graft survival; kidney (allograft)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Kidney Transplantation Type of study: Observational_studies / Systematic_reviews Limits: Humans Language: En Journal: Clin Transplant Journal subject: TRANSPLANTE Year: 2021 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google